Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1998 2
2001 4
2002 3
2003 1
2004 3
2005 3
2006 3
2007 4
2009 2
2010 7
2011 1
2012 1
2013 2
2014 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancer.
Tetzlaff MT, Teh BS, Timme TL, Fujita T, Satoh T, Tabata K, Mai WY, Vlachaki MT, Amato RJ, Kadmon D, Miles BJ, Ayala G, Wheeler TM, Aguilar-Cordova E, Thompson TC, Butler EB. Tetzlaff MT, et al. Among authors: vlachaki mt. Technol Cancer Res Treat. 2006 Feb;5(1):23-36. doi: 10.1177/153303460600500104. Technol Cancer Res Treat. 2006. PMID: 16417399 Free article. Review.
A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck.
Varveris H, Mazonakis M, Vlachaki M, Kachris S, Lyraraki E, Zoras O, Maris T, Froudarakis M, Velegrakis J, Perysinakis C, Damilakis J, Samonis G. Varveris H, et al. Among authors: vlachaki m. Oncol Rep. 2003 Jan-Feb;10(1):185-95. doi: 10.3892/or.10.1.185. Oncol Rep. 2003. PMID: 12469168 Clinical Trial.
Red yeast rice for dyslipidemia in statin-intolerant patients.
Kolpakchi AL, Chukwu II, Vlachaki MT. Kolpakchi AL, et al. Among authors: vlachaki mt. Ann Intern Med. 2010 Jan 19;152(2):133-4; author reply 135-6. doi: 10.7326/0003-4819-152-2-201001190-00023. Ann Intern Med. 2010. PMID: 20083838 No abstract available.
Combining radiotherapy with gene therapy (from the bench to the bedside): a novel treatment strategy for prostate cancer.
Teh BS, Aguilar-Cordova E, Vlachaki MT, Aguilar L, Mai WY, Caillouet J, Davis M, Miles B, Kadmon D, Ayala G, Lu HH, Chiu JK, Carpenter LS, Woo SY, Grant WH 3rd, Wheeler T, Thompson TC, Butler EB. Teh BS, et al. Among authors: vlachaki mt. Oncologist. 2002;7(5):458-66. doi: 10.1634/theoncologist.7-5-458. Oncologist. 2002. PMID: 12401909 Free article. Clinical Trial.
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
Fujita T, Satoh T, Timme TL, Hirayama T, Zhu JX, Kusaka N, Naruishi K, Yang G, Goltsov A, Wang J, Vlachaki MT, Teh BS, Brian Butler E, Thompson TC. Fujita T, et al. Among authors: vlachaki mt. Urol Oncol. 2014 Feb;32(2):92-100. doi: 10.1016/j.urolonc.2012.10.007. Epub 2013 Feb 20. Urol Oncol. 2014. PMID: 23433894 Free PMC article.
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T, Timme TL, Tabata K, Naruishi K, Kusaka N, Watanabe M, Abdelfattah E, Zhu JX, Ren C, Ren C, Yang G, Goltsov A, Wang H, Vlachaki MT, Teh BS, Butler EB, Thompson TC. Fujita T, et al. Among authors: vlachaki mt. Gene Ther. 2007 Feb;14(3):227-36. doi: 10.1038/sj.gt.3302788. Epub 2006 Oct 5. Gene Ther. 2007. PMID: 17024109
39 results